维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="LANKAS GR"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Dipeptidyl peptidase IVinhibition for the treatment of type 2 diabetes: potentialimportance of selectivity over dipeptidyl peptidases 8 and 9显示文摘	Lankas GR Leiting B Roy RS	2005	Diabetes2005，54，10：	1
2	Placen- tal P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice显示文摘	Lankas GR Wise LD Cartwright ME	1998	Re- prod Toxicol1998，12，4：	1
3	Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9显示文摘	LANKAS GR LEITING B ROY RS	2005	Diabetes2005，54，10：	1
4	Induction of reversible urothelial cell hyperplasia in rats by clorsulon, a flukicide with weak carbonic anhydrase inhibitory activity显示文摘	Peterr CP	1992	Food ChemToxicol1992，30，4：	1
5	Dipeptidyl peptidase Ⅳ inhibition for the treatment of type 2 diabetes:potential importance of selectivity over dipeptidyl peptidases 8 and 9显示文摘	LANKAS GR LEITING B ROY RS	2005	Diabetes2005，54，10：	1
6	Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice显示文摘	Wise LD Cartwright ME	1998	Reprod Toxicol1998，12，：	1
7	Dipeptidyl peptidase IV inhibition for the treatment of potential importance of selectivity over dipeptidyl peptidase 8 and 9显示文摘	Lankas GR Leiting B Ray RS	2005	Diabetes2005，54，10：	1
8	Dipeptidyl peptidase IV inhibitionfor the treatment of type 2 diabetes: potential importance of selectivityover dipeptidyl peptidases 8 and 9显示文摘	Lankas GR Leiting B Roy RS	2005	Diabetes2005，54，10：	1
9	Dipeptidyl peptidase Ⅳ inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9 显示文摘	Lankas GR Leifing B Roy RS	2005	Diabetes2005，54，10：	1
10	Placental P- glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice 显示文摘	Lankas GR Wise LD Cartwright ME	1998	Reprod Toxicol1998，12，：	1
11	Dipeptidyl peptidase Ⅳ inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9 显示文摘	Lankas GR Leiting B Roy RS	2005	Diabetes2005，54，10：	1
12	Dipeptidyl pepti-dase IV inhibition for the treatment of type 2 diabetes po-tential importance of selectivity over dipeptidyl peptidases 8 and 9显示文摘	Lankas GR Leiting B Roy RS		0，，10：	1
13	Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9显示文摘	Lankas GR Leiting B Roy RS	2005	Diabetes2005，54，10：	1
14	Dipeptidyl peptidase Ⅳ inhibition for the treatment of type 2 diabetes:potential importance of selectivity over dipeptidyl peptidases 8 and 9显示文摘	Lankas GR Leiting B Roy RS	2005	Diabetes2005，54，10：	1
15	Identification of a P-glycoprotein-deficient subpopulation in the CF-1 mouse strain using a restriction fragments length polymorphism显示文摘	Umbenhauer DR Lankas GR Pippert TR	1997	Toxicol Appl Pharmacol1997，146，：	1
16	Identi- ffication of a P-glycoprotein-deficient subpopulation in the CF-1 mouse strain using a restriction fragment length polymorphism 显示文摘	Umbenhauer DR Lankas GR Pippert TR	1997	Toxicol Appl Pharmacol1997，146，：	1
17	Placental p- glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice显示文摘	Lankas GR Wise LD Cartwright ME	1998	Reprod Toxicol1998，12，4：	1
18	Placental P- glycoprotein deficiency enhances susceptibility to chem- ically induced birth defects in mice 显示文摘	Lankas GR Wise LD Cartwright ME	1998	Reprod Toxicol1998，12，：	1
19	Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9 显示文摘	LANKAS GR LEITING B ROY RS	2005	Diabetes2005，54，10：	1
20	Placental P-glycoprotein deficiency enhances susceptibility to chemi- cally induced birth defects in mice 显示文摘	Lankas GR Wise LD Cartwright ME Pippert T Umbenhauer DR	1998	Reprod Toxicol1998，12，4：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示